HEADER TRANSFERASE/TRANSFERASE INHIBITOR 20-DEC-18 6NFH TITLE BTK IN COMPLEX WITH INHIBITOR 8-(2,3-DIHYDRO-1H-INDEN-5-YL)-2-({4- TITLE 2 [(2S)-3-(DIMETHYLAMINO)-2-HYDROXYPROPOXY]PHENYL}AMINO)-5,8- TITLE 3 DIHYDROPTERIDINE-6,7-DIONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 389-659); COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE, ATK, B-CELL PROGENITOR COMPND 6 KINASE, BPK, BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BRUTON TYROSINE KINASE, BTK, KINASE, BTK INHIBITOR, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.MIRZADEGAN,K.L.DAMM-GANAMET REVDAT 3 11-OCT-23 6NFH 1 REMARK REVDAT 2 12-JUN-19 6NFH 1 JRNL REVDAT 1 13-MAR-19 6NFH 0 JRNL AUTH K.L.DAMM-GANAMET,N.ARORA,S.BECART,J.P.EDWARDS,A.D.LEBSACK, JRNL AUTH 2 H.M.MCALLISTER,M.I.NELEN,N.L.RAO,L.WESTOVER,J.J.M.WIENER, JRNL AUTH 3 T.MIRZADEGAN JRNL TITL ACCELERATING LEAD IDENTIFICATION BY HIGH THROUGHPUT VIRTUAL JRNL TITL 2 SCREENING: PROSPECTIVE CASE STUDIES FROM THE PHARMACEUTICAL JRNL TITL 3 INDUSTRY. JRNL REF J.CHEM.INF.MODEL. V. 59 2046 2019 JRNL REFN ESSN 1549-960X JRNL PMID 30817167 JRNL DOI 10.1021/ACS.JCIM.8B00941 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 49736 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.160 REMARK 3 R VALUE (WORKING SET) : 0.156 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.200 REMARK 3 FREE R VALUE TEST SET COUNT : 5022 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3593 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.50 REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE SET COUNT : 375 REMARK 3 BIN FREE R VALUE : 0.3380 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2214 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 276 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.14000 REMARK 3 B22 (A**2) : -0.46000 REMARK 3 B33 (A**2) : -0.67000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.074 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.070 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.049 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.868 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2480 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1730 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3363 ; 1.433 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4199 ; 1.414 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 308 ; 6.171 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 112 ;31.361 ;23.929 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 446 ;12.297 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;12.780 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 345 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2813 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 529 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 4210 ; 2.689 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6NFH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1000238266. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99987 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54763 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 59.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05900 REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.65 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.48100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1K2P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 31% W/V PEG5000 MME, 0.1 M MES, PH REMARK 280 6.5, 0.1 M AMMONIUM SULFATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 36.06150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.18350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.06150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.18350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 400 NZ REMARK 480 LYS A 433 CE NZ REMARK 480 GLU A 434 CG CD OE1 OE2 REMARK 480 GLN A 496 CD OE1 NE2 REMARK 480 LYS A 595 NZ REMARK 480 GLU A 624 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 520 -8.53 78.42 REMARK 500 ASP A 521 50.54 -154.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KLM A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 704 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 706 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 707 DBREF 6NFH A 389 659 UNP Q06187 BTK_HUMAN 389 659 SEQRES 1 A 271 GLY LEU GLY TYR GLY SER TRP GLU ILE ASP PRO LYS ASP SEQRES 2 A 271 LEU THR PHE LEU LYS GLU LEU GLY THR GLY GLN PHE GLY SEQRES 3 A 271 VAL VAL LYS TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL SEQRES 4 A 271 ALA ILE LYS MET ILE LYS GLU GLY SER MET SER GLU ASP SEQRES 5 A 271 GLU PHE ILE GLU GLU ALA LYS VAL MET MET ASN LEU SER SEQRES 6 A 271 HIS GLU LYS LEU VAL GLN LEU TYR GLY VAL CYS THR LYS SEQRES 7 A 271 GLN ARG PRO ILE PHE ILE ILE THR GLU TYR MET ALA ASN SEQRES 8 A 271 GLY CYS LEU LEU ASN TYR LEU ARG GLU MET ARG HIS ARG SEQRES 9 A 271 PHE GLN THR GLN GLN LEU LEU GLU MET CYS LYS ASP VAL SEQRES 10 A 271 CYS GLU ALA MET GLU TYR LEU GLU SER LYS GLN PHE LEU SEQRES 11 A 271 HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP SEQRES 12 A 271 GLN GLY VAL VAL LYS VAL SER ASP PHE GLY LEU SER ARG SEQRES 13 A 271 TYR VAL LEU ASP ASP GLU TYR THR SER SER VAL GLY SER SEQRES 14 A 271 LYS PHE PRO VAL ARG TRP SER PRO PRO GLU VAL LEU MET SEQRES 15 A 271 TYR SER LYS PHE SER SER LYS SER ASP ILE TRP ALA PHE SEQRES 16 A 271 GLY VAL LEU MET TRP GLU ILE TYR SER LEU GLY LYS MET SEQRES 17 A 271 PRO TYR GLU ARG PHE THR ASN SER GLU THR ALA GLU HIS SEQRES 18 A 271 ILE ALA GLN GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SEQRES 19 A 271 SER GLU LYS VAL TYR THR ILE MET TYR SER CYS TRP HIS SEQRES 20 A 271 GLU LYS ALA ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SEQRES 21 A 271 SER ASN ILE LEU ASP VAL MET ASP GLU GLU SER HET KLM A 701 36 HET EDO A 702 4 HET EDO A 703 4 HET EDO A 704 4 HET EDO A 705 4 HET EDO A 706 4 HET EDO A 707 4 HETNAM KLM 8-(2,3-DIHYDRO-1H-INDEN-5-YL)-2-({4-[(2S)-3- HETNAM 2 KLM (DIMETHYLAMINO)-2-HYDROXYPROPOXY]PHENYL}AMINO)-5,8- HETNAM 3 KLM DIHYDROPTERIDINE-6,7-DIONE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 KLM C26 H28 N6 O4 FORMUL 3 EDO 6(C2 H6 O2) FORMUL 9 HOH *276(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 ASN A 451 1 14 HELIX 3 AA3 CYS A 481 GLU A 488 1 8 HELIX 4 AA4 MET A 489 ARG A 492 5 4 HELIX 5 AA5 GLN A 494 LYS A 515 1 22 HELIX 6 AA6 ALA A 523 ARG A 525 5 3 HELIX 7 AA7 GLY A 541 VAL A 546 5 6 HELIX 8 AA8 PRO A 560 SER A 564 5 5 HELIX 9 AA9 PRO A 565 SER A 572 1 8 HELIX 10 AB1 SER A 575 SER A 592 1 18 HELIX 11 AB2 THR A 602 GLN A 612 1 11 HELIX 12 AB3 SER A 623 CYS A 633 1 11 HELIX 13 AB4 LYS A 637 ARG A 641 5 5 HELIX 14 AB5 THR A 643 GLU A 658 1 16 SHEET 1 AA1 5 LEU A 402 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O GLY A 414 N GLY A 411 SHEET 3 AA1 5 TYR A 425 ILE A 432 -1 O MET A 431 N VAL A 415 SHEET 4 AA1 5 ILE A 470 THR A 474 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N TYR A 461 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 -3.30 SITE 1 AC1 13 LEU A 408 GLY A 409 THR A 410 VAL A 416 SITE 2 AC1 13 ALA A 428 LYS A 430 THR A 474 GLU A 475 SITE 3 AC1 13 MET A 477 GLY A 480 LEU A 528 HOH A 807 SITE 4 AC1 13 HOH A 898 SITE 1 AC2 6 HIS A 635 GLU A 636 HOH A 802 HOH A 804 SITE 2 AC2 6 HOH A 900 HOH A 933 SITE 1 AC3 7 TYR A 598 GLU A 599 ARG A 600 PHE A 601 SITE 2 AC3 7 HOH A 821 HOH A 833 HOH A 917 SITE 1 AC4 7 TYR A 476 ALA A 478 ASN A 530 ASP A 531 SITE 2 AC4 7 HOH A 812 HOH A 966 HOH A1035 SITE 1 AC5 7 LYS A 400 LYS A 573 ARG A 618 HIS A 620 SITE 2 AC5 7 ALA A 622 SER A 623 HOH A1076 SITE 1 AC6 7 ARG A 525 LYS A 558 PHE A 559 PRO A 560 SITE 2 AC6 7 TRP A 563 HOH A 868 HOH A 903 SITE 1 AC7 5 VAL A 458 SER A 538 ASP A 539 PHE A 540 SITE 2 AC7 5 LEU A 542 CRYST1 72.123 104.367 38.140 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013865 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009582 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026219 0.00000